Browse
S-Space
College of Medicine/School of Medicine (의과대학/대학원)
Dept. of Medicine (의학과)
Journal Papers (저널논문_의학과)
A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas
- Authors
- Issue Date
- 2021-08
- Publisher
- Ferrata Storti Foundation
- Citation
- Haematologica, Vol.106 No.8, pp.2277-2280
- ISSN
- 0390-6078
- Files in This Item: There are no files associated with this item.
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.